{
  "ptid_time": "014_S_4576_2012-03-08",
  "img_path": "/data/qiuhui/data/adni/images/014_S_4576/2012-03-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 14,345 mm³, 48.9% below the reference mean. With a Z-score of -1.12 (13.1th percentile), this represents mild atrophy; hippocampal volume measures 8,436 mm³, 18.6% above the reference mean. With a Z-score of 1.70 (95.6th percentile), this represents moderate enlargement; whole brain volume measures 959,169 mm³, 1.6% below the reference mean. With a Z-score of -0.20 (42.1th percentile), this represents normal volume ; entorhinal cortex volume measures 4,088 mm³, 11.3% above the reference mean. With a Z-score of 0.69 (75.6th percentile), this represents normal volume ; fusiform gyrus volume measures 16,983 mm³, 0.2% below the reference mean. With a Z-score of -0.02 (49.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,309 mm³, 0.7% above the reference mean. With a Z-score of 0.06 (52.5th percentile), this represents normal volume . ",
  "text_data": "Age is 70.5 years. Gender is Female. Education: 14 years. Handedness: Right. Race: Black or African American. Medical history: Head, Eyes, Ears, Nose and Throat; Respiratory; Musculoskeletal; Endocrine-Metabolic; Hematopoietic-Lymphatic. MMSE: 30.0. MoCA: 28.0. Logical Memory: 17.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.11 SUVR (normal ); Total tau: 590.10 pg/mL (profound elevated); Phosphorylated tau: 55.14 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume data shows mild ventricular atrophy but otherwise normal or even enlarged volumes in key regions (hippocampus, entorhinal cortex). Cognitive scores (MMSE 30, MoCA 28) are intact, but biomarkers (profoundly elevated T-tau and P-tau) suggest Alzheimer’s pathology. The absence of APOE4 and normal AV45 (amyloid PET) complicates the picture, as tau elevation without amyloid is atypical for AD.  \n\n**Diagnosis:** **MCI** (biomarkers indicate neurodegeneration, but cognition is preserved).  \n**Confidence:** **Medium** (conflicting biomarker patterns—tau elevation without amyloid or APOE4 raises questions about non-AD tauopathy).  \n\n*Note: If clinical symptoms emerge (e.g., memory complaints), reassessment would be warranted. The tau elevation may reflect a primary tauopathy (e.g., PART) rather than typical AD.*",
  "timestamp": "2025-07-25T23:55:28.318828"
}